Cargando…

Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD

BACKGROUND: Histone deacetylase (HDAC) is an enzyme that regulates chromatin structure and inflammatory gene expression. In patients with chronic obstructive pulmonary disease (COPD), while accumulating evidence indicates that the activity of HDAC is decreased in lung tissue alveolar macrophages, HD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanwei, Huang, Ping, Ai, Wen, Li, Xiaoli, Guo, Wei, Zhang, Jingnong, Yang, Jiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359164/ https://www.ncbi.nlm.nih.gov/pubmed/22443498 http://dx.doi.org/10.1186/1476-9255-9-10

Ejemplares similares

Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients
por: Tan, Chunting, et al.
Publicado: (2016)

Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes
por: Hodge, Greg, et al.
Publicado: (2015)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
por: Cosio, Borja G., et al.
Publicado: (2004)

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD
por: Footitt, Joseph, et al.
Publicado: (2016)

Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7
por: To, Masako, et al.
Publicado: (2012)

Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
por: Lu, Guang, et al.
Publicado: (2023)

Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood–Brain Barrier After Stroke
por: Lu, Hui, et al.
Publicado: (2022)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
por: Li, Guo, et al.
Publicado: (2020)

Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
por: Chavez-Blanco, Alma, et al.
Publicado: (2005)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors
por: Zheng, Zhong, et al.
Publicado: (2014)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Deletion of Histone Deacetylase 7 in Osteoclasts Decreases Bone Mass in Mice by Interactions with MITF
por: Stemig, Melissa, et al.
Publicado: (2015)

Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress
por: Mercado, Nicolas, et al.
Publicado: (2011)

HISTONE DEACETYLASE 6 interaction with ABSCISIC ACID-INSENSITIVE 5 decreases apple drought tolerance
por: Li, Wenjie, et al.
Publicado: (2023)

Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
por: Huang, Ying, et al.
Publicado: (2011)

Decreased phagocytic function in neutrophils and monocytes from peripheral blood in periodontal disease
por: CARNEIRO, Valéria Martins Araújo, et al.
Publicado: (2012)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases
por: Das Gupta, Kaustav, et al.
Publicado: (2016)

Histone deacetylase inhibitor during in vitro maturation decreases developmental capacity of bovine oocytes
por: Pontelo, Thais Preisser, et al.
Publicado: (2021)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Changes in Airway Histone Deacetylase2 in Smokers and COPD with Inhaled Corticosteroids: A Randomized Controlled Trial
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

Increased Histone Acetylation and Decreased Expression of Specific Histone Deacetylases in Ultraviolet-Irradiated and Intrinsically Aged Human Skin In Vivo
por: Lee, Yuri, et al.
Publicado: (2021)

In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs
por: Wang, Changning, et al.
Publicado: (2014)

Diversity, evolution and expression profiles of histone acetyltransferases and deacetylases in oomycetes
por: Wang, Xiao-Wen, et al.
Publicado: (2016)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis
por: Zheng, Hanxi, et al.
Publicado: (2023)

Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases
por: Han, Anna, et al.
Publicado: (2018)

Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
por: Hai, Yang, et al.
Publicado: (2017)

IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors
por: Shu, Jin, et al.
Publicado: (2017)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Histone deacetylases in RA: epigenetics and epiphenomena
por: Grabiec, Aleksander M, et al.
Publicado: (2010)

Histone deacetylase inhibitors in Hodgkin lymphoma
por: Buglio, Daniela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ehknucegmmseiaso30h11g6fg1